Insulet
PODD · NASDAQ
Bulios Fair Price
$117.3
16.6% downside
Current Price
$140.62
According to Bulios Fair Price, PODD is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Insulet Corporation (PODD) is an American company specializing in the development and manufacturing of innovative medical devices for diabetes management. Their main product is the Omnipod, which is a wireless insulin pump system. Omnipod is designed to provide simplicity and convenience for patients with type 1 and type 2 diabetes, allowing them to manage their insulin regimen wirelessly. Insulet Corporation also focuses on developing other technologies and products in the field of diabetes management to improve the lives of patients with this condition. Insulet Corporation (PODD) shares may be attractive to investors seeking investments in companies operating in the medical device sector with an emphasis on innovation and improving care for patients with diabetes mellitus.
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley McEvoy
Employees
5,400
Headquarters
Acton
Upcoming events
Earnings
Upcoming earnings report